Folgen
Antonella Torosantucci
Antonella Torosantucci
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei iss.it
Titel
Zitiert von
Zitiert von
Jahr
A novel glyco-conjugate vaccine against fungal pathogens
A Torosantucci, C Bromuro, P Chiani, F De Bernardis, F Berti, C Galli, ...
The Journal of experimental medicine 202 (5), 597-606, 2005
5092005
Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin‐1 beta‐glucan receptor and Toll‐like receptor 2
K Luther, A Torosantucci, AA Brakhage, J Heesemann, F Ebel
Cellular microbiology 9 (2), 368-381, 2007
2522007
In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors
A Cassone, F De Bernardis, A Torosantucci, E Tacconelli, M Tumbarello, ...
The Journal of infectious diseases 180 (2), 448-453, 1999
2481999
Protection by anti-β-glucan antibodies is associated with restricted β-1, 3 glucan binding specificity and inhibition of fungal growth and adherence
A Torosantucci, P Chiani, C Bromuro, F De Bernardis, AS Palma, Y Liu, ...
PloS one 4 (4), e5392, 2009
2412009
An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal …
A Rachini, D Pietrella, P Lupo, A Torosantucci, P Chiani, C Bromuro, ...
Infection and immunity 75 (11), 5085-5094, 2007
1852007
An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal …
A Rachini, D Pietrella, P Lupo, A Torosantucci, P Chiani, C Bromuro, ...
Infection and immunity 75 (11), 5085-5094, 2007
1852007
Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study
R Cauda, E Tacconelli, M Tumbarello, G Morace, F De Bernardis, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 21 (1), 20-25, 1999
1781999
Beta-glucan-CRM197 conjugates as candidates antifungal vaccines
C Bromuro, M Romano, P Chiani, F Berti, M Tontini, D Proietti, E Mori, ...
Vaccine 28 (14), 2615-2623, 2010
1532010
Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine
C Bromuro, A Torosantucci, P Chiani, S Conti, L Polonelli, A Cassone
Infection and immunity 70 (10), 5462-5470, 2002
1342002
Antiretroviral Therapy with Protease Inhibitors Has an Early, Immune Reconstitution–Independent Beneficial Effect on Candida Virulence and Oral Candidiasis in …
A Cassone, E Tacconelli, F De Bernardis, M Tumbarello, A Torosantucci, ...
The Journal of infectious diseases 185 (2), 188-195, 2002
1052002
Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans
MJ Gomez, A Torosantucci, S Arancia, B Maras, L Parisi, A Cassone
Infection and immunity 64 (7), 2577-2584, 1996
1021996
The interaction of human dendritic cells with yeast and germ-tube forms of Candida albicans leads to efficient fungal processing, dendritic cell maturation, and …
G Romagnoli, R Nisini, P Chiani, S Mariotti, R Teloni, A Cassone, ...
Journal of Leucocyte Biology 75 (1), 117-126, 2004
962004
Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the β-1,6 glucan of the fungal cell wall
A Torosantucci, P Chiani, A Cassone
Journal of leukocyte biology 68 (6), 923-932, 2000
922000
A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice
A Mencacci, A Torosantucci, R Spaccapelo, L Romani, F Bistoni, ...
Infection and immunity 62 (12), 5353-5360, 1994
911994
A β-glucan-conjugate vaccine and anti-β-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique
D Pietrella, A Rachini, A Torosantucci, P Chiani, AJP Brown, F Bistoni, ...
Vaccine 28 (7), 1717-1725, 2010
902010
Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans
L Angiolella, AR Stringaro, F De Bernardis, B Posteraro, M Bonito, ...
Antimicrobial agents and Chemotherapy 52 (3), 927-936, 2008
842008
In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall
A Vecchiarelli, M Puliti, A Torosantucci, A Cassone, F Bistoni
Cellular immunology 134 (1), 65-76, 1991
841991
Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species
A Cassone, A Torosantucci, M Boccanera, G Pellegrini, C Palma, ...
Journal of medical microbiology 27 (4), 233-238, 1988
831988
Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species
A Cassone, A Torosantucci, M Boccanera, G Pellegrini, C Palma, ...
Journal of medical microbiology 27 (4), 233-238, 1988
831988
Identification of a 65-kDa Mannoprotein as a Main Target of Human CellMediated Immune Response to Candida albicans
A Torosantucci, C Bromuro, MJ Gomez, CM Ausiello, F Urbani, ...
Journal of Infectious Diseases 168 (2), 427-435, 1993
761993
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20